The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways

In this study, glioblastoma inhibition was acheived via the disruption of IL17A, which blocks angiogenesis using new derivatives of rosmarinic acid (RA). Anti-GBM activity of the compounds were determined through cell migration and cell proliferation assays with U87 MG, DBTRG MG, and EA.hy 926 cells...

Description complète

Détails bibliographiques
Auteur principal: Khan, Md Shamsuddin Sultan
Format: Thèse
Langue:anglais
Publié: 2017
Sujets:
Accès en ligne:http://eprints.usm.my/47701/
Abstract Abstract here
_version_ 1855629958427181056
author Khan, Md Shamsuddin Sultan
author_facet Khan, Md Shamsuddin Sultan
author_sort Khan, Md Shamsuddin Sultan
description In this study, glioblastoma inhibition was acheived via the disruption of IL17A, which blocks angiogenesis using new derivatives of rosmarinic acid (RA). Anti-GBM activity of the compounds were determined through cell migration and cell proliferation assays with U87 MG, DBTRG MG, and EA.hy 926 cells. Antiangiogenic activity was investigated with tube formation, CAM, and aortic explant assays. The compounds’ activity in IL17A and VEGF expression was determined using ELISA and their apoptotic activity was assessed by the Caspase assay. The cancer pathway was determined using the reporter gene assay.
first_indexed 2025-10-17T08:32:46Z
format Thesis
id usm-47701
institution Universiti Sains Malaysia
language English
last_indexed 2025-10-17T08:32:46Z
publishDate 2017
record_format EPrints
record_pdf Restricted
spelling usm-477012020-10-22T08:34:47Z http://eprints.usm.my/47701/ The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways Khan, Md Shamsuddin Sultan RS1-441 Pharmacy and materia medica In this study, glioblastoma inhibition was acheived via the disruption of IL17A, which blocks angiogenesis using new derivatives of rosmarinic acid (RA). Anti-GBM activity of the compounds were determined through cell migration and cell proliferation assays with U87 MG, DBTRG MG, and EA.hy 926 cells. Antiangiogenic activity was investigated with tube formation, CAM, and aortic explant assays. The compounds’ activity in IL17A and VEGF expression was determined using ELISA and their apoptotic activity was assessed by the Caspase assay. The cancer pathway was determined using the reporter gene assay. 2017-09 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/47701/1/THE%20DEVELOPMENT%20OF%20ROSMARINIC%20ACID.pdf%20cut.pdf Khan, Md Shamsuddin Sultan (2017) The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways. PhD thesis, Universiti Sains Malaysia.
spellingShingle RS1-441 Pharmacy and materia medica
Khan, Md Shamsuddin Sultan
The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
thesis_level PhD
title The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_full The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_fullStr The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_full_unstemmed The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_short The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_sort development of rosmarinic acid derivatives to target il17a in glioblastoma multiforme via angiogenic pathways
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/47701/
work_keys_str_mv AT khanmdshamsuddinsultan thedevelopmentofrosmarinicacidderivativestotargetil17ainglioblastomamultiformeviaangiogenicpathways
AT khanmdshamsuddinsultan developmentofrosmarinicacidderivativestotargetil17ainglioblastomamultiformeviaangiogenicpathways